Health technology assessment and reimbursement of pharmaceuticals in Italy

QR Code

Health technology assessment and reimbursement of pharmaceuticals in Italy

The Italian healthcare system is historically structured by the difference in economic development between the northern and southern parts of this country. The Italian Medicines Agency (AIFA) is the national health technology assessment (HTA) authority in charge of the reimbursement and formulary-li...

Full description

Saved in:

Bibliographic Details
Main Authors:	F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2019-07-01
Series:	Фармакоэкономика
Subjects:	health technology assessment drug provision governmental pharmaceuticals reimbursement italy
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/295
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The health technology assessment system in Australia
by: V. V. Omelyanovskiy, et al.
Published: (2020-02-01)

How should medicines reimbursement work? The views of Spanish experts
by: Juan Carlos Rejon-Parrilla, et al.

What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01)

Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
by: V. A. Lemeshko, et al.
Published: (2021-04-01)

Drug provision and health technology assessment in France
by: V. V. Omelyanovskiy, et al.
Published: (2020-04-01)

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
by: A. S. Kolbin, et al.
Published: (2016-04-01)

Introduction of medical products into healthcare practice and costs reimbursement: European experience
by: V. V. Omelyanovsky, et al.
Published: (2018-08-01)

Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice
by: N. A. Bilousova
Published: (2024-11-01)

Problems of pharmaceutical provision of population with hypolipidemic drugs: the case of the Volgograd region (the Russian Federation)
by: I. N. Tyurenkov, et al.
Published: (2020-05-01)

Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis
by: J. A. Agafonova, et al.
Published: (2025-02-01)

Encyclopedia of pharmaceutical technology /
Published: (1988)

Affordability of in vivo gene therapy. Problems and potential solutions
by: V. V. Omelyanovskiy, et al.
Published: (2020-08-01)

APPROACHES TO REIMBURSEMENT FOR MEDICAL CARE WITHIN ANESTHESIOLOGY AND INTENSIVE CARE PROFILE DURING TRANSFER TO A NEW SYSTEM OF HEALTH CARE FUNDING
by: Yu. S. Polushin, et al.
Published: (2018-01-01)

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018-11-01)

Analysis of Factors Affecting Medical Cost and Insurance Reimbursement Gaps in Hypertension Heart Failure Patients
by: Nurma Suri, et al.
Published: (2025-06-01)

Study of affordability of pharmaceutical provision for type 2 diabetes therapy in Ukraine
by: I.O. Vlasenko, et al.
Published: (2025-06-01)

Mental health: current trends in pharmacy and new concepts
by: N. A. Bilousova, et al.
Published: (2023-11-01)

PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION
by: L. S. Melnikova
Published: (2015-06-01)

Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation
by: V. V. Omelyanovskiy, et al.
Published: (2024-11-01)

IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?
by: V. V. Omelyanovskiy
Published: (2015-05-01)

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871
by: V. V. Omelyanovskiy, et al.
Published: (2020-08-01)

A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs
by: Marilisa Pia Dimmito, et al.
Published: (2025-03-01)

The Quality Risk Assessment of Paralithodes Camtschaticus Collagenase Gel in the Process of Pharmaceutical Development
by: Ju. O. Ivankova, et al.
Published: (2023-09-01)

ORGANIZATION OF PHARMACEUTICAL AID IN SOLVING THE PROBLEM OF EXCESS WEIGHT IN THE POPULATION
by: G. Ya. Ibragimova, et al.
Published: (2017-12-01)

Fascism in Italy : its development and influence /
by: Wiskemann, Elizabeth
Published: (1969)

PROBLEMS AND PERSPECTIVES OF MEDICINAL PROVISION OF RUSSIAN AND ARMENIAN POPULATION
by: M. S. Koshel, et al.
Published: (2015-09-01)

Real-world clinical practice in health technology assessment: state of the art for 2022
by: A. A. Kurylev, et al.
Published: (2023-01-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Art and architecture in Italy, 1600 to 1750 /
by: Wittkower, Rudolf
Published: (1958)

Development of Retraining Systems for the Implementation of the Pharmaceutical Quality System at Pharmaceutical Production Enterprises of the EAEU Countries
by: V. A. Smirnov, et al.
Published: (2021-02-01)

Pharmaceutical care as a historical, normative-legal and social-economic category in the system of the population health and pharmaceutical care
by: G. L. Panfilova
Published: (2014-08-01)

Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice
by: M. S. Soboleva
Published: (2023-07-01)

STUDY OF PHARMACEUTICAL SPECIALISTS’ INFORMATION AWARENESS ON THE MATTERS OF DRUG ABUSE
by: N. Yu. Porseva, et al.
Published: (2021-05-01)

ANALYSIS OF INDUSTRIAL PRACTICE OF DRUG QUALITY RISK MANAGEMENT IN RUSSIAN PHARMACEUTICAL ENTERPRISES
by: A. B. Kashirina, et al.
Published: (2021-03-01)

Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
by: S. A. Rozhnova, et al.
Published: (2019-11-01)

PHARMACEUTICAL PARTNERSHIPS IN THE DEVELOPMENT OF NEW PHARMACEUTICALS
by: A. L. Bulgakov, et al.
Published: (2018-03-01)

Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation
by: I. К. Petrukhina, et al.
Published: (2023-01-01)

Real-world data: principles of use in decision making and in health technology assessment
by: V. V. Omelyanovskiy, et al.
Published: (2023-07-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

Reflection of Political Struggle in Italy in Documents of Communist International (1919—1923)
by: E. N. Emelyanova
Published: (2024-01-01)